Fonte: Journal of Clinical Oncology. Nome do evento: Annual Meeting of the American Society of Clinical Oncology. Unidade: FM
Assuntos: QUIMIOTERAPIA, NEOPLASIAS DE CABEÇA E PESCOÇO (RADIOTERAPIA), SEGUIMENTOS, PROGNÓSTICO, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, G. et al. Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 03 nov. 2025. , 2005APA
Castro, G., Snitcovsky, I. M. L., Gebrim, E. M., Leitao, G. M., Rocha, C. N., Nadalin, W., et al. (2005). Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Castro G, Snitcovsky IML, Gebrim EM, Leitao GM, Rocha CN, Nadalin W, Ferraz AR, Federico MH. Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 2005 ; 23( 16S ): 522s.[citado 2025 nov. 03 ]Vancouver
Castro G, Snitcovsky IML, Gebrim EM, Leitao GM, Rocha CN, Nadalin W, Ferraz AR, Federico MH. Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC). Journal of Clinical Oncology. 2005 ; 23( 16S ): 522s.[citado 2025 nov. 03 ]
